Purit Co Ltd

Purit Co Ltd maintains a strong liquidity position, with a current ratio of 4.24, indicating that the company has more than four times the current assets to cover its current liabilities. The company also holds KRW 10,761,716,210 in cash and equivalents, which supports its short-term financial flexibility. The debt-to-equity ratio is 0.0, suggesting that the company is not leveraged and relies primarily on equity financing. In terms of profitability, Purit Co Ltd reports a return on equity (ROE) of 14.1% and a return on assets (ROA) of 12.35%, both of which are strong indicators of efficient capital use and asset management. These metrics are well above the typical thresholds for the Commodity Chemicals industry, where ROE and ROA are often lower due to the capital-intensive nature of the sector. The company's revenue is concentrated in a single business line focused on coal chemical compounds and waste solvent recovery, with no disclosed geographic diversification. This lack of segment or geographic diversification may increase exposure to regional demand fluctuations and supply chain disruptions. Purit Co Ltd has demonstrated consistent revenue and profit generation, with a net income of KRW 15,154,734,390 and operating income of KRW 17,217,719,370. While no forward-looking revenue growth rates are provided, the company's strong operating cash flow of KRW 22,336,549,170 and free cash flow of KRW 10,386,334,500 suggest a stable and cash-generative business model. The company's risk profile is low, with no immediate filing-based liquidity or dilution flags detected. The absence of long-term debt and the presence of a large equity base further reduce financial risk. However, the lack of capital expenditure (KRW -8,551,218,330) may indicate a conservative approach to reinvestment, which could limit long-term growth potential. No recent events, such as filings or transcripts, were disclosed in the provided data. The company appears to be operating in a stable environment without significant near-term regulatory or market disruptions.